Content about Gilead Sciences

March 17, 2011
Gilead, Roche sue Natco Pharma over generic Tamiflu

Drug makers Gilead Sciences and Roche are suing Indian drug maker Natco Pharma concerning a generic version of an influenza treatment, according to published reports.

March 4, 2011
FDA lifts liver injury risk boxed warning from Gilead's Letairis

Gilead on Friday announced that the Food and Drug Administration has removed a boxed warning about a possible liver injury risk caused by the drug maker's hypertension treatment.

February 23, 2011
Gilead to acquire Calistoga

Drug maker Gilead Sciences plans to buy out a privately owned Seattle company that makes treatments for cancer and inflammatory diseases, Gilead said Tuesday.

February 14, 2011
Gilead resubmits HIV drug application to FDA

Gilead Sciences has refiled an approval application with the Food and Drug Administration for an HIV drug, the drug maker said.

November 22, 2010
New drug from Gilead may prevent HIV infection, study finds

NEW YORK A daily dose of an anti-retroviral pill appears to prevent HIV infection, according to results of a study conducted by University of California at San Francisco researchers, published in The New England Journal of Medicine on Tuesday.

September 26, 2010
REPORTERS Notebook

Greenstone announced the launch of an authorized generic version of the Alzheimer’s disease drug Aricept...

September 12, 2010
Gilead: 'Quad' anti-retroviral drug as effective as competitor

An investigational treatment for HIV by Gilead Sciences that combines four drugs in one tablet...

August 30, 2010
Sigmapharm files ANDA for generic Hepsera

A generic drug maker has filed an abbreviated new drug application for its version of...

July 18, 2010
Kaletra-Isentress therapy for HIV patients as effective as standard treatments, drug makers say

A combination therapy comprising of drugs made by Abbott and Merck is as effective as...

July 14, 2010
Gilead sues Lupin over patent infringement

Drug maker Gilead Sciences has filed a suit against Indian generic drug maker Lupin for...

June 27, 2010
Gilead to acquire CGI

Gilead Sciences plans to acquire a development-stage pharmaceutical company for up to $120 million, Gilead...

June 13, 2010
Gilead patent for Ranexa challenged by Lupin

Indian generic drug maker Lupin is challenging a Gilead Sciences patent for a drug that...

June 1, 2010
Decision Resources projects peak sales for three HIV drugs

Three new drugs for treating HIV from Gilead Sciences and J&J subsidiary Tibotec could have...

January 31, 2010
Teva files ANDA for generic version of HIV drug

Teva is hoping to release its version of an HIV drug before the drug’s patents...

© 2013 Drug Store News. All Rights Reserved.